Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D'Hondt, L.A."'
Autor:
Seront, E., Rottey, S., Sautois, B., Kerger, J., D'Hondt, L.A., Verschaeve, V., Canon, J.-L., Dopchie, C., Vandenbulcke, J.M., Whenham, N., Goeminne, J.C., Clausse, M., Verhoeven, D., Glorieux, P., Branders, S., Dupont, P., Schoonjans, J., Feron, O., Machiels, J.-P. *
Publikováno v:
In Annals of Oncology October 2012 23(10):2663-2670
Autor:
Baldin, P., Beniuga, G., Jouret-Mourin, A., Demolin, G., Roland, S., D'Hondt, L.A., Vergauwe, P., Vandaele, D., Mailleux, M., Sinapi, I., De Cuyper, A., Bletard, N., Massart, B., Delos, M., Castella, M-L., van Maanen, A., Carrasco, J., van den Eynde, M.
Publikováno v:
In Annals of Oncology September 2020 31 Supplement 4:S433-S433
Autor:
Verschaeve, V, D'hondt, L.a., Verbeke, L.m.j., Van Fraeyenhove, F, Du Four, Stephanie, Duerinck, Johnny, Neyns, Bart
Background: The overall survival (OS) of newly diagnosed glioblastoma (GB) patients (pts) treated with RT and TMZ is correlated with the methylation status of the MGMT-promoter. Pts with an unmethylated MGMT-promoter in particular have a poor prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::646d7cc96839f174468c4caaad9474aa
https://biblio.vub.ac.be/vubir/a-randomized-noncomparative-phase-ii-clinical-trial-of-the-effect-of-radiation-therapy-rt-plus-temozolomide-tmz-combined-with-cilengitide-or-cetuximab-on-the-1year-overall-survival-of-patients-with-newly-diagnosed-mgmtpromoter-unmethylated-glioblastoma(273ff53d-92eb-4330-b9a2-6d04b59c23f2).html
https://biblio.vub.ac.be/vubir/a-randomized-noncomparative-phase-ii-clinical-trial-of-the-effect-of-radiation-therapy-rt-plus-temozolomide-tmz-combined-with-cilengitide-or-cetuximab-on-the-1year-overall-survival-of-patients-with-newly-diagnosed-mgmtpromoter-unmethylated-glioblastoma(273ff53d-92eb-4330-b9a2-6d04b59c23f2).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.